Estimations des analystes de Wall Street pour Organogenesis Holdings Inc. (ORGO): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 4 |
| Conserver | 1 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 5 |
| Note moyenne (1-5) | 0.80 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-05 | $-0.18 | ||
| 2026-08-06 | $-0.71 | $-0.35 | -102.9% |
| 2026-05-07 | $-0.37 | $-0.29 | -27.6% |
| 2026-02-26 | $0.31 | $0.21 | +44.2% |
| 2025-11-06 | $0.18 | $0.21 | -14.3% |
| 2025-08-07 | $-0.09 | $0.07 | -228.6% |
| 2025-05-08 | $-0.13 | $0.04 | -425.0% |
| 2025-02-27 | $0.04 | $-0.03 | +233.3% |
Ratios de valorisation
| Prix / Valeur comptable | 0.62 |
| EV / EBITDA | -50.95 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | 0 | 0 | $193.4M | $261.0M | $338.3M | $467.4M | $450.9M | $433.1M | $482.0M | $563.0M |
| Coût des Ventes | $208698 | $4.6M | $68.8M | $75.9M | $87.3M | $114.2M | $105.0M | $106.5M | $115.7M | $137.5M |
| Marge Brute | -$208698 | -$4.6M | $124.6M | $185.0M | $251.0M | $353.2M | $345.9M | $326.7M | $366.3M | $425.5M |
| R&D | 0 | 0 | $10.7M | $14.8M | $20.1M | $30.7M | $39.8M | $44.4M | $50.3M | $44.5M |
| Frais Généraux | $208698 | $4.6M | $162.0M | $200.1M | $204.2M | $250.2M | $283.8M | $269.8M | $294.5M | $326.2M |
| Charges Opérationnelles | $208698 | $4.6M | $172.7M | $214.9M | $224.3M | $280.9M | $323.6M | $314.1M | $367.6M | $369.6M |
| Résultat Opérationnel | $208698 | -$4.6M | -$51.6M | -$29.9M | $26.7M | $72.2M | $22.3M | $12.5M | -$1.3M | $55.9M |
| EBITDA | $7.1M | -$2.1M | -$46.9M | -$19.7M | $37.2M | $87.0M | $40.3M | $36.0M | $15.8M | $73.9M |
| Charges d'Intérêt | $5.6M | $8.0M | $10.9M | $9.0M | $11.3M | $7.2M | $2.0M | $2.2M | $1.5M | 0 |
| Résultat Avant Impôts | -$208698 | -$2.1M | -$64.7M | -$38.6M | $17.8M | $63.1M | $20.3M | $10.4M | -$2.8M | $47.0M |
| Impôts | -$440212 | -$52516 | $84000 | $150000 | $530000 | -$31.1M | $4.8M | $5.4M | -$3.7M | $9.9M |
| Résultat Net | -$208698 | -$2.1M | -$64.8M | -$38.7M | $17.2M | $94.2M | $15.5M | $4.9M | $861000 | $37.0M |
| BPA | $-0.02 | $-0.03 | $-0.94 | $-0.44 | $0.16 | $0.73 | $0.12 | $0.04 | $-0.01 | $0.16 |
| BPA Dilué | $-0.02 | $-0.03 | $-0.94 | $-0.44 | $0.15 | $0.70 | $0.12 | $0.04 | $-0.01 | $0.15 |
| Actions en Circulation (Diluées) | $8.6M | $63.9M | $69.3M | $92.8M | $111.4M | $133.7M | $132.4M | $132.7M | $131.7M | $130.2M |
Prix
| Prix | $1.39 |
| Capitalisation | $179M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ANGO · BCYC · CMPX · EBS · EOLS · ESPR · MNPR
Explorer le secteur: Healthcare · Drug Manufacturers - Specialty & Generic
Plus de sections de ORGO: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions